Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Nevro Corp before investing.

In this article, we go over a few key elements for understanding Nevro Corp’s stock price such as:

• Nevro Corp’s current stock price and volume
• Why Nevro Corp’s stock price changed recently
• Upgrades and downgrades for NVRO from analysts
• NVRO’s stock price momentum as measured by its relative strength

About Nevro Corp (NVRO)

Before we jump into Nevro Corp’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.

Want to learn more about Nevro Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Nevro Corp.

Nevro Corp’s Stock Price as of Market Close

As of May 21, 2024, 4:00 PM, CST, Nevro Corp’s stock price was $9.96.

Nevro Corp is down 5.32% from its previous closing price of $10.52.

During the last market session, Nevro Corp’s stock traded between $10.50 and $11.45. Currently, there are 36.47 million shares of Nevro Corp stock available for purchase.

Unfortunately, Nevro Corp’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Nevro Corp Stock Price History

Nevro Corp’s (NVRO) price is currently down 5.86% so far this month.

During the month of May, Nevro Corp’s stock price has reached a high of $11.79 and a low of $9.76.

Over the last year, Nevro Corp has hit prices as high as $28.42 and as low as $9.76. Year to date, Nevro Corp’s stock is down 74.85%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Nevro Corp Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 20, 2024, there were 10 analysts who downgraded Nevro Corp’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Nevro Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Nevro Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Nevro Corp’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Nevro Corp (NVRO) by visiting AAII Stock Evaluator.

Relative Price Strength of Nevro Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 20, 2024, Nevro Corp has a weighted four-quarter relative price strength of -27.49%, which translates to a Momentum Score of 11 and is considered to be Very Weak.

Want to learn more about how Nevro Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Nevro Corp Stock Price: Bottom Line

As of May 21, 2024, Nevro Corp’s stock price is $9.96, which is down 5.32% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Nevro Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.